|Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials|
DM Zulman, JB Sussman, X Chen, CT Cigolle, CS Blaum, RA Hayward
Journal of general internal medicine 26 (7), 783-790, 2011
|Evidence-based risk communication: a systematic review|
DA Zipkin, CA Umscheid, NL Keating, E Allen, KK Aung, R Beyth, S Kaatz, ...
Annals of internal medicine 161 (4), 270-280, 2014
|Effect of patients’ risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus|
S Vijan, JB Sussman, JS Yudkin, RA Hayward
JAMA internal medicine 174 (8), 1227-1234, 2014
|Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care|
TJ Iwashyna, JF Burke, JB Sussman, HC Prescott, RA Hayward, ...
American journal of respiratory and critical care medicine 192 (9), 1045-1051, 2015
|An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials|
JB Sussman, RA Hayward
Bmj 340, 2010
|Three simple rules to ensure reasonably credible subgroup analyses|
JF Burke, JB Sussman, DM Kent, RA Hayward
Bmj 351, 2015
|Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus|
JB Sussman, EA Kerr, SD Saini, RG Holleman, ML Klamerus, LC Min, ...
JAMA internal medicine 175 (12), 1942-1949, 2015
|Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis|
V Chopra, DH Wesorick, JB Sussman, T Greene, M Rogers, JB Froehlich, ...
Archives of Surgery 147 (2), 181-189, 2012
|Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk|
S Yadlowsky, RA Hayward, JB Sussman, RL McClelland, YI Min, S Basu
Annals of internal medicine 169 (1), 20-29, 2018
|Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis|
S Basu, JS Yudkin, S Kehlenbrink, JI Davies, SH Wild, KJ Lipska, ...
The lancet Diabetes & endocrinology 7 (1), 25-33, 2019
|Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program|
JB Sussman, DM Kent, JP Nelson, RA Hayward
Bmj 350, 2015
|Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials|
S Basu, JB Sussman, SA Berkowitz, RA Hayward, JS Yudkin
The lancet Diabetes & endocrinology 5 (10), 788-798, 2017
|Improved cardiovascular risk prediction using nonparametric regression and electronic health record data|
EH Kennedy, WL Wiitala, RA Hayward, JB Sussman
Medical care 51 (3), 251, 2013
|Using benefit-based tailored treatment to improve the use of antihypertensive medications|
J Sussman, S Vijan, R Hayward
Circulation 128 (21), 2309-2317, 2013
|Benefit and harm of intensive blood pressure treatment: derivation and validation of risk models using data from the SPRINT and ACCORD trials|
S Basu, JB Sussman, J Rigdon, L Steimle, BT Denton, RA Hayward
PLoS medicine 14 (10), e1002410, 2017
|Validation of risk equations for complications of type 2 diabetes (RECODe) using individual participant data from diverse longitudinal cohorts in the US|
S Basu, JB Sussman, SA Berkowitz, RA Hayward, AG Bertoni, A Correa, ...
Diabetes care 41 (3), 586-595, 2018
|Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis|
BJ Elmunzer, AG Singal, JB Sussman, AR Deshpande, DA Sussman, ...
Gastrointestinal endoscopy 81 (3), 700-709. e3, 2015
|Sex differences in cognitive decline among US adults|
DA Levine, AL Gross, EM Briceņo, N Tilton, BJ Giordani, JB Sussman, ...
JAMA network open 4 (2), e210169-e210169, 2021
|Detecting heterogeneous treatment effects to guide personalized blood pressure treatment: a modeling study of randomized clinical trials|
S Basu, JB Sussman, RA Hayward
Annals of internal medicine 166 (5), 354-360, 2017
|Serum NfL (neurofilament light chain) levels and incident stroke in adults with diabetes mellitus|
FK Korley, J Goldstick, M Mastali, JE Van Eyk, W Barsan, WJ Meurer, ...
Stroke 50 (7), 1669-1675, 2019